BioCentury
ARTICLE | Company News

Myriad Genetics, Kaiser Permanente sales and marketing update

February 22, 2000 8:00 AM UTC

Kaiser will offer MYGN's BRACAnalysis test for breast and ovarian cancer susceptibility testing to patients with hereditary risk. ...